Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Pet Vaccine Market Report 2017

  • QYR1051953
  • 108 Pages
  • March 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the United States Pet Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Pet Vaccine in these regions, from 2012 to 2022 (forecast).

United States Pet Vaccine market competition by top manufacturers/players, with Pet Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Bayer Healthcare

Vetoquinol S.A

Boehringer Ingelheim

Ceva

Eli Lilly

Heska Co.

Merck Animal Health

Merial (Sanofi)

Virbac

Zoetis (Pfizer)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

Attenuated Live Vaccines

Conjugate Vaccines

Inactivated Vaccines

Subunit Vaccines

Toxoid Vaccines

DNA Vaccines

Recombinant Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pet Vaccine for each application, including

Canine

Avian

Feline

Table of Contents

United States Pet Vaccine Market Report 2017

1 Pet Vaccine Overview

1.1 Product Overview and Scope of Pet Vaccine

1.2 Classification of Pet Vaccine by Product Category

1.2.1 United States Pet Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Pet Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Attenuated Live Vaccines

1.2.4 Conjugate Vaccines

1.2.5 Inactivated Vaccines

1.2.6 Subunit Vaccines

1.2.7 Toxoid Vaccines

1.2.8 DNA Vaccines

1.2.9 Recombinant Vaccines

1.3 United States Pet Vaccine Market by Application/End Users

1.3.1 United States Pet Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Canine

1.3.3 Avian

1.3.4 Feline

1.4 United States Pet Vaccine Market by Region

1.4.1 United States Pet Vaccine Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Pet Vaccine Status and Prospect (2012-2022)

1.4.3 Southwest Pet Vaccine Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Pet Vaccine Status and Prospect (2012-2022)

1.4.5 New England Pet Vaccine Status and Prospect (2012-2022)

1.4.6 The South Pet Vaccine Status and Prospect (2012-2022)

1.4.7 The Midwest Pet Vaccine Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Pet Vaccine (2012-2022)

1.5.1 United States Pet Vaccine Sales and Growth Rate (2012-2022)

1.5.2 United States Pet Vaccine Revenue and Growth Rate (2012-2022)

2 United States Pet Vaccine Market Competition by Players/Suppliers

2.1 United States Pet Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Pet Vaccine Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Pet Vaccine Average Price by Players/Suppliers (2012-2017)

2.4 United States Pet Vaccine Market Competitive Situation and Trends

2.4.1 United States Pet Vaccine Market Concentration Rate

2.4.2 United States Pet Vaccine Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Pet Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Pet Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Pet Vaccine Sales and Market Share by Region (2012-2017)

3.2 United States Pet Vaccine Revenue and Market Share by Region (2012-2017)

3.3 United States Pet Vaccine Price by Region (2012-2017)

4 United States Pet Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Pet Vaccine Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Pet Vaccine Revenue and Market Share by Type (2012-2017)

4.3 United States Pet Vaccine Price by Type (2012-2017)

4.4 United States Pet Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Pet Vaccine Sales (Volume) by Application (2012-2017)

5.1 United States Pet Vaccine Sales and Market Share by Application (2012-2017)

5.2 United States Pet Vaccine Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Pet Vaccine Players/Suppliers Profiles and Sales Data

6.1 Bayer Healthcare

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Pet Vaccine Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Vetoquinol S.A

6.2.2 Pet Vaccine Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Boehringer Ingelheim

6.3.2 Pet Vaccine Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Ceva

6.4.2 Pet Vaccine Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Ceva Pet Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Eli Lilly

6.5.2 Pet Vaccine Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Eli Lilly Pet Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Heska Co.

6.6.2 Pet Vaccine Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Heska Co. Pet Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Merck Animal Health

6.7.2 Pet Vaccine Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Merck Animal Health Pet Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Merial (Sanofi)

6.8.2 Pet Vaccine Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Virbac

6.9.2 Pet Vaccine Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Virbac Pet Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Zoetis (Pfizer)

6.10.2 Pet Vaccine Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

7 Pet Vaccine Manufacturing Cost Analysis

7.1 Pet Vaccine Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Pet Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Pet Vaccine Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Pet Vaccine Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Pet Vaccine Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Pet Vaccine Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Pet Vaccine Sales Volume Forecast by Type (2017-2022)

11.3 United States Pet Vaccine Sales Volume Forecast by Application (2017-2022)

11.4 United States Pet Vaccine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Pet Vaccine

Figure United States Pet Vaccine Market Size (K Doses) by Type (2012-2022)

Figure United States Pet Vaccine Sales Volume Market Share by Type (Product Category) in 2016

Figure Attenuated Live Vaccines Product Picture

Figure Conjugate Vaccines Product Picture

Figure Inactivated Vaccines Product Picture

Figure Subunit Vaccines Product Picture

Figure Toxoid Vaccines Product Picture

Figure DNA Vaccines Product Picture

Figure Recombinant Vaccines Product Picture

Figure United States Pet Vaccine Market Size (K Doses) by Application (2012-2022)

Figure United States Sales Market Share of Pet Vaccine by Application in 2016

Figure Canine Examples

Figure Avian Examples

Figure Feline Examples

Figure United States Pet Vaccine Market Size (Value) by Region (2012-2022)

Figure The West Pet Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Pet Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Pet Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Pet Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Pet Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Pet Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Pet Vaccine Sales (K Doses) and Growth Rate (2012-2022)

Figure United States Pet Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Pet Vaccine Market Major Players Product Sales Volume (2012-2017)

Table United States Pet Vaccine Sales (K Doses) of Key Players/Suppliers (2012-2017)

Table United States Pet Vaccine Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Pet Vaccine Sales Share by Players/Suppliers

Figure 2017 United States Pet Vaccine Sales Share by Players/Suppliers

Figure United States Pet Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Pet Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Pet Vaccine Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Pet Vaccine Revenue Share by Players/Suppliers

Figure 2017 United States Pet Vaccine Revenue Share by Players/Suppliers

Table United States Market Pet Vaccine Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)

Figure United States Market Pet Vaccine Average Price of Key Players/Suppliers in 2016

Figure United States Pet Vaccine Market Share of Top 3 Players/Suppliers

Figure United States Pet Vaccine Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Pet Vaccine Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Pet Vaccine Product Category

Table United States Pet Vaccine Sales (K Doses) by Region (2012-2017)

Table United States Pet Vaccine Sales Share by Region (2012-2017)

Figure United States Pet Vaccine Sales Share by Region (2012-2017)

Figure United States Pet Vaccine Sales Market Share by Region in 2016

Table United States Pet Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Pet Vaccine Revenue Share by Region (2012-2017)

Figure United States Pet Vaccine Revenue Market Share by Region (2012-2017)

Figure United States Pet Vaccine Revenue Market Share by Region in 2016

Table United States Pet Vaccine Price (USD/Dose) by Region (2012-2017)

Table United States Pet Vaccine Sales (K Doses) by Type (2012-2017)

Table United States Pet Vaccine Sales Share by Type (2012-2017)

Figure United States Pet Vaccine Sales Share by Type (2012-2017)

Figure United States Pet Vaccine Sales Market Share by Type in 2016

Table United States Pet Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Pet Vaccine Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Pet Vaccine by Type (2012-2017)

Figure Revenue Market Share of Pet Vaccine by Type in 2016

Table United States Pet Vaccine Price (USD/Dose) by Types (2012-2017)

Figure United States Pet Vaccine Sales Growth Rate by Type (2012-2017)

Table United States Pet Vaccine Sales (K Doses) by Application (2012-2017)

Table United States Pet Vaccine Sales Market Share by Application (2012-2017)

Figure United States Pet Vaccine Sales Market Share by Application (2012-2017)

Figure United States Pet Vaccine Sales Market Share by Application in 2016

Table United States Pet Vaccine Sales Growth Rate by Application (2012-2017)

Figure United States Pet Vaccine Sales Growth Rate by Application (2012-2017)

Table Bayer Healthcare Basic Information List

Table Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Bayer Healthcare Pet Vaccine Sales Growth Rate (2012-2017)

Figure Bayer Healthcare Pet Vaccine Sales Market Share in United States (2012-2017)

Figure Bayer Healthcare Pet Vaccine Revenue Market Share in United States (2012-2017)

Table Vetoquinol S.A Basic Information List

Table Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Vetoquinol S.A Pet Vaccine Sales Growth Rate (2012-2017)

Figure Vetoquinol S.A Pet Vaccine Sales Market Share in United States (2012-2017)

Figure Vetoquinol S.A Pet Vaccine Revenue Market Share in United States (2012-2017)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Boehringer Ingelheim Pet Vaccine Sales Growth Rate (2012-2017)

Figure Boehringer Ingelheim Pet Vaccine Sales Market Share in United States (2012-2017)

Figure Boehringer Ingelheim Pet Vaccine Revenue Market Share in United States (2012-2017)

Table Ceva Basic Information List

Table Ceva Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Ceva Pet Vaccine Sales Growth Rate (2012-2017)

Figure Ceva Pet Vaccine Sales Market Share in United States (2012-2017)

Figure Ceva Pet Vaccine Revenue Market Share in United States (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Eli Lilly Pet Vaccine Sales Growth Rate (2012-2017)

Figure Eli Lilly Pet Vaccine Sales Market Share in United States (2012-2017)

Figure Eli Lilly Pet Vaccine Revenue Market Share in United States (2012-2017)

Table Heska Co. Basic Information List

Table Heska Co. Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Heska Co. Pet Vaccine Sales Growth Rate (2012-2017)

Figure Heska Co. Pet Vaccine Sales Market Share in United States (2012-2017)

Figure Heska Co. Pet Vaccine Revenue Market Share in United States (2012-2017)

Table Merck Animal Health Basic Information List

Table Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Merck Animal Health Pet Vaccine Sales Growth Rate (2012-2017)

Figure Merck Animal Health Pet Vaccine Sales Market Share in United States (2012-2017)

Figure Merck Animal Health Pet Vaccine Revenue Market Share in United States (2012-2017)

Table Merial (Sanofi) Basic Information List

Table Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Merial (Sanofi) Pet Vaccine Sales Growth Rate (2012-2017)

Figure Merial (Sanofi) Pet Vaccine Sales Market Share in United States (2012-2017)

Figure Merial (Sanofi) Pet Vaccine Revenue Market Share in United States (2012-2017)

Table Virbac Basic Information List

Table Virbac Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Virbac Pet Vaccine Sales Growth Rate (2012-2017)

Figure Virbac Pet Vaccine Sales Market Share in United States (2012-2017)

Figure Virbac Pet Vaccine Revenue Market Share in United States (2012-2017)

Table Zoetis (Pfizer) Basic Information List

Table Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Zoetis (Pfizer) Pet Vaccine Sales Growth Rate (2012-2017)

Figure Zoetis (Pfizer) Pet Vaccine Sales Market Share in United States (2012-2017)

Figure Zoetis (Pfizer) Pet Vaccine Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Pet Vaccine

Figure Manufacturing Process Analysis of Pet Vaccine

Figure Pet Vaccine Industrial Chain Analysis

Table Raw Materials Sources of Pet Vaccine Major Players/Suppliers in 2016

Table Major Buyers of Pet Vaccine

Table Distributors/Traders List

Figure United States Pet Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)

Figure United States Pet Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Pet Vaccine Price (USD/Dose) Trend Forecast (2017-2022)

Table United States Pet Vaccine Sales Volume (K Doses) Forecast by Type (2017-2022)

Figure United States Pet Vaccine Sales Volume (K Doses) Forecast by Type (2017-2022)

Figure United States Pet Vaccine Sales Volume (K Doses) Forecast by Type in 2022

Table United States Pet Vaccine Sales Volume (K Doses) Forecast by Application (2017-2022)

Figure United States Pet Vaccine Sales Volume (K Doses) Forecast by Application (2017-2022)

Figure United States Pet Vaccine Sales Volume (K Doses) Forecast by Application in 2022

Table United States Pet Vaccine Sales Volume (K Doses) Forecast by Region (2017-2022)

Table United States Pet Vaccine Sales Volume Share Forecast by Region (2017-2022)

Figure United States Pet Vaccine Sales Volume Share Forecast by Region (2017-2022)

Figure United States Pet Vaccine Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370